Day: September 27, 2021

Altimmune to Announce 12-Week Data From ALT-801 Phase 1 Trial on September 28, 2021

GAITHERSBURG, Md., Sept. 27, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report the results from its 12-week Phase 1 clinical trial of ALT-801 in overweight and obese subjects in a pre-market press release and webcast to be held on Tuesday, September 28, 2021. Altimmune management will host a conference call and webcast with a slide presentation beginning at 8:30 am E.T. Following the conclusion of the call, the webcast will be available for replay on the Investor Relations page of the Company’s website at www.altimmune.com. The company has used, and intends to continue to use, the IR portion of its website as a means of disclosing material non-public information and for complying with disclosure obligations under Regulation FD. Conference Call...

Continue reading

Evercel Sets Record Straight on Misleading Claims By Former Chairman

Issues Letter to Shareholders Urging Them to Vote on WHITE Proxy Card in Support of Two Highly Qualified Candidates MIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) — Evercel, Inc. [OTC Pink: EVRC] (the “Company”) today issued the following letter to shareholders from its Board of Directors in advance of its Annual Meeting on October 7, 2021, urging them to vote on the WHITE proxy card in support of the Board’s two unopposed candidates, Richard Perkins and Patrick McGeehin. The letter also sets the record straight on a series of misleading claims made by the former Chairman. The text of the letter is below: Dear Valued Shareholders: We are writing in advance of the upcoming Annual Meeting to encourage you to vote your shares using the official WHITE Evercel proxy card enclosed. The official WHITE proxy card will allow you to vote for or...

Continue reading

Sovos Brands, Inc. Announces Closing of Public Offering

LOUISVILLE, Colo., Sept. 27, 2021 (GLOBE NEWSWIRE) —  Sovos Brands, Inc. (“Sovos Brands”) (Nasdaq: SOVO) announced today the closing of its initial public offering of 23,334,000 shares of its common stock at a price to the public of $12.00 per share. Gross proceeds to Sovos Brands were approximately $280.0 million, before underwriting discounts and commissions and estimated offering expenses. The common stock began trading on the Nasdaq Global Select Market on September 23, 2021. Sovos Brands has granted the underwriters a 30-day option to purchase up to an additional 3,500,100 shares of common stock at the initial public offering price, less the underwriting discounts and commissions. J.P. Morgan and Goldman Sachs acted as joint lead book-running managers for the offering and as representatives of the underwriters. BofA Securities,...

Continue reading

Opus One Gold Corp Retains Market Making Services

NOT FOR DISTRIBUTION TO U.S NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, Sept. 27, 2021 (GLOBE NEWSWIRE) — Opus One Gold Corp (TSX-V: OOR) (the “Company” or “Opus One”) is pleased to announce that, subject to regulatory approval, it has retained the market making services of Integral Wealth Securities Ltd. (“Integral”) to provide assistance in maintaining an orderly trading market for the common shares of the Company posted for listing on the TSX Venture Exchange (the “TSX-V”). The market-making service will be undertaken by Integral in compliance with the applicable policies of the TSX-V and other applicable laws. For its services, the Company has agreed to pay Integral a fee of seven thousand five hundred dollars ($7,500) per month for a period of 3 months. The agreement between the Company...

Continue reading

INmune Bio, Inc. to Participate in the B. Riley Fall 2021 Best Ideas in Oncology Series

Boca Raton, FL, Sept. 27, 2021 (GLOBE NEWSWIRE) —  INmune Bio, Inc. (NASDAQ: INMB) (the, “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced that Mark Lowdell, PhD, Chief Scientific Officer and Chief Medical Officer, will be participating in an oncology panel at the B. Riley Fall 2021 Best Ideas in Oncology Series. Panel details: Title: Improving Strategies to Harness the Immune System Date: Thursday, September 30, 2021 Time: 9:00am ET This event is open to institutional investors. Interested parties may register for the panel here.      About INmune Bio, Inc. INmune Bio, Inc. is a publicly traded (NASDAQ: INMB), clinical-stage biotechnology company focused on developing treatments that target the innate immune system...

Continue reading

CBD Global Sciences Resumes Trading After Filing of Financials

Denver, Colorado, Sept. 27, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — CBD Global Sciences, Inc. (OTC: CBDNF) (CSE: CBDN) (Frankfurt:GS3), (“CBD Global” or the “Company”), is pleased to share the news that, following the filing of its 2020 annual, and Q1 2021 and Q2 2021 financial statements and MD&A, the previously issued cease trade order has been revoked and the Company’s common shares have been approved by the regulators and Canadian Securities Exchange to resume trading.   The Company’s common shares will resume trading at the opening of the market on September 28, 2021.  The financials submitted paint a picture of a company that has fought vigorously to survive through the impact of the global pandemic in 2020 and predatory litigation that led to the filing of Chapter 7 bankruptcies for two of its subsidiary companies...

Continue reading

PROREIT Announces Agreements to Acquire 16 Industrial Assets for an Aggregate Purchase Price of $163.2 Million, $60 Million Bought Deal Public Offering of Trust Units and $14 Million Concurrent Private Placement

NOT FOR DISSEMINATION IN THE UNITED STATES OR DISTRIBUTION THROUGH UNITED STATES NEWS OR WIRE SERVICES. Acquisition of 16 institutional quality industrial assets comprising total GLA of 1,181,006 square feet PROREIT portfolio to increase to 6.6 million square feet of GLA and approximately $928 million of total assets, pro forma the Transactions Increased exposure to industrial segment, representing 78% of GLA and 63% of base rent pro forma the Transactions Transactions accretive to AFFO/unit* and expected to reduce AFFO payout ratio* on a leverage neutral basis Enhanced liquidity through significant pay down of credit facilities MONTREAL, Sept. 27, 2021 (GLOBE NEWSWIRE) — PRO Real Estate Investment Trust (TSX: PRV.UN) (“PROREIT” or the “REIT”) today announced that it has entered into agreements to acquire...

Continue reading

Tingo Inc. Nominated in Environmental, Social & Governance Category at Upcoming Crypto AM Awards

LOS ANGELES, Sept. 27, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Tingo Inc. (OTCQB: IWBB) is a unique agri-fintech company offering, through Tingo Mobile in Nigeria, personal communications services (“PCS”) using GSM technology for subscribers within and outside of the agricultural sector. Tingo Mobile has developed a comprehensive agri-fintech and agri-marketplace ecosystem to support the agricultural sector, becoming Africa’s leading provider of such services over the long term. Services include smartphone leasing, agri-marketplace, airtime top-ups, utilities payments, bill pay, and access to insurance and lending services. This is collectively known as NWASSA, a service to support financial inclusion and deliver significant social impact in the agriculture sector. It supports rural communities in line with UN SDGs and...

Continue reading

Cenovus and Headwater announce bought deal secondary offering of Headwater common shares worth approximately $114 million

Not for distribution to U.S. newswire services or dissemination in the United States CALGARY, Alberta, Sept. 27, 2021 (GLOBE NEWSWIRE) — Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) (“Cenovus” or the “Selling Shareholder”) and Headwater Exploration Inc. (TSX: HWX) (“Headwater” or the “Company”) announced today that they have entered into an agreement with Peters & Co. Limited and BMO Capital Markets (the “Lead Underwriters”), on behalf of a syndicate of underwriters (together with the Lead Underwriters, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, from Cenovus, through its wholly owned subsidiary, Cenovus Marten Hills Partnership (the “Partnership”), 25,000,000 common shares of the Company (the “Common Shares”) at a price of $4.55 per Common Share (the “Offering Price”)...

Continue reading

PyroGenesis Signs Joint-Venture Agreement to Build and Operate Plants to Convert Aluminum Dross Residues into High Value Chemical Products

Complements Existing Portfolio of Green Solutions Catering to the Aluminum Industry MONTREAL, Sept. 27, 2021 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (NASDAQ: PYR) (TSX: PYR) (FRA: 8PY), a high-tech company (hereinafter referred to as the “Company” or “PyroGenesis”), that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions to reduce greenhouse gases, is pleased to announce today that, further to its Q2 2021 financial results press release (section Outlook) dated August 16th, it has signed joint venture and license agreements (both agreements collectively the “JV”) with a leading residue processor (the “Partner”) to transform dross residues into high value chemical products. “This is a very interesting addition to PyroGenesis’ offerings as it fits perfectly...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.